Search

everythinglearnresearchcommunity

for

Search:↓

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

The treatment might help COVID-19 related hair loss, but more research is needed.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

A woman with Castleman's disease died from respiratory failure due to bronchiolitis obliterans.

Inward rectifier potassium channels are important in many body functions and diseases, and could be potential drug targets.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

A young Russian girl with Meier-Gorlin syndrome has two new mutations in the CDC6 gene.

Modified PRP therapy successfully treated severe alopecia unresponsive to traditional methods.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Severe hair loss significantly worsens quality of life.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Certain fungi protect skin health, but changes can allow harmful fungi to cause serious infections, needing more research for treatment and control.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

People with Collagen VI-related myopathies may often have hair loss and scalp issues.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

A woman with childhood growth hormone deficiency had multiple hormone deficiencies and developed serious lung and kidney problems later in life.